Morse E, et al. - Experts ascertained the treatment delays in surgically treated oropharyngeal cancer. They also identified the factors related to delays and how delays impact survival. Findings suggested 27, 42, 47, 90, and 106 days to be median durations of diagnosis-to-treatment initiation, surgery-to-radiation treatment, radiation treatment duration, total treatment package, and diagnosis-to-treatment end intervals, respectively. An relationship between delays and Medicaid and human papillomavirus (HPV) negativity was noted. An association of delayed total treatment package and diagnosis-to-treatment end intervals with decreased survival was seen, and this was maintained after HPV stratification. Results suggested applying distinct benchmarks to HPV-negative and HPV-positive patients.